Vivex Biologics chairman John McCallum breaks down the challenges, costs, and strategies behind bringing medical innovations ...

Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...

WA biotech Orthocell has received US Food and Drug Administration clearance for its flagship nerve repair product.

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.

As of March 24, 2025, both the FDA and the American Society of Health-System Pharmacists (ASHP) websites have listed branded ...

President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...

The U.S. Supreme Court upheld a series of decisions on Thursday by the US Food and Drug Administration to keep flavored ...

The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...

This regenerative medicine company is up more than 260% in the last year. The post This company has entered a trading halt, ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...